drugset / Trial / NCT05113888
Exploratory Study on Dosage of Qizhi Weitong Granules in the Treatment of Irritable Bowel Syndrome (IBS)
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study are as follows: 1) To evaluate the efficacy and safety of Qizhi Weitong granules in the treatment of diarrhea-type irritable bowel syndrome (IBS-D);2) To explore the dosage of Qizhi Weitong Granulesin treatment of IBS-D.
Timeline
- Start
- 2021-12-01
- Primary completion
- 2022-08-31
- Completion
- 2022-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Qizhi Weitong Granules | Unknown | 2.5 g | Oral |
| Subject | Qizhi Weitong Granules | Unknown | 5 g | Oral |